Survodutide

FDA-approved GLP-1 medications and their generic active ingredients.

Definition

Boehringer Ingelheim and Zealand Pharma's investigational dual agonist of GLP-1 and glucagon receptors. Phase 2 reported up to 19% weight loss at 46 weeks. The phase 3 SYNCHRONIZE program is enrolled; not yet FDA-approved.

GLP-1 pipeline: survodutide, MariTide, ecnoglutide →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Drugs and brands

Wegovy
Ozempic
Rybelsus
Saxenda
Zepbound
Mounjaro
Foundayo
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
MariTide (Maridebart Cafraglutide)
Ecnoglutide

Looking for more depth?

GLP-1 pipeline: survodutide, MariTide, ecnoglutide
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers